Kepley BioSystems awarded prestigious NSF TECP Grant
The initial design sketch for the OrganoBait automated production module to be funded by NSF TECP grant.
KBI is an academically inspired enterprise committed to the development and commercialization of a patent-pending, synthetic crustacean bait to conserve billions of wild fish otherwise wasted merely as bait for lobster and crab fishing. Specifically, the KBI mission is to supply the $66 billion global crustacean fishing industry with an affordable, synthetic bait to avert the industrial plunder and consequent, dwindling populations of forage fish and the unintended by-catch of dolphins, turtles and other marine life destroyed in their capture.
To design the automated manufacturing module, KBI will partner with Mr. Robert Barry, founder of Nova Product Design, a skilled firm that specializes in industrial and mechanical design. During the TECP period, KBI will also continue an ongoing advisory relationship with Mark Pfister, sales manager of Atlantic & Gulf Fishing Supply Corporation in Miami, Florida. Atlantic & Gulf supplies fishing materials to a wide range of crustacean fishers globally.
“This is a momentous opportunity for Kepley BioSystems,” says research scientist, Lee Robertson. “The continued NSF support for our synthetic bait project will allow us to produce products at commercial volumes and bring OrganoBait to market. We are especially thrilled to be working with Nova to bring the technology to the next level."
ABOUT KEPLEY BIOSYSTEMS
Kepley BioSystems originated at the Joint School of Nanoscience and Nanoengineering (JSNN), North Carolina A&T State University and the University of North Carolina at Greensboro the company is now located at the Gateway University Research Park proximal to JSNN. Kepley BioSystems is an academically-driven company led by Professor Christopher Kepley and Dr. Anthony Dellinger, a recent graduate, working in collaboration with lead inventor Terry E. Brady, located on the Caribbean island of Anguilla, British West Indies.
For more information, Visit: http://www.kepleybiosystems.com/
Anthony L. Dellinger, President of Kepley BioSystems, Inc. Adjunct Research at the Joint School of Nanoscience and Nanoengineering
Kepley BioSystems, Inc.
2901 East Gate City Blvd Suite 2400
Greensboro, NC, 27401
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kepley BioSystems awarded prestigious NSF TECP Grant here
News-ID: 382369 • Views: 493
More Releases for OrganoBait
Kepley BioSystems Incorporated selected as finalist in 2016 NC IDEA challenge
Greensboro, NC, November 1, 2016 -- Kepley BioSystems announced today that their team has been selected as a Top 25 finalist in the 2016 NC IDEA grant program. NC IDEA provides semi-annual grant solicitations for ideas with the potential to become high-growth companies. The grant program is a catalyst for technological breakthroughs developed in North Carolina that have a significant potential to successfully transition commercially viable high-growth enterprise. Their mission
Kepley BioSystems in Top Tier at Hello Tomorrow Global Summit
Tuesday, October 18, 2016, Greensboro, N.C.: Kepley BioSystems (KBI) was a finalist from among 3,500 original contestants, which narrowed to representatives of 500 deep-technology start-ups invited to participate in the third Hello Tomorrow Global Summit. The event took place last week on October 13-14, 2016, at the Le Centquatre conference center in Paris. The Global Summit, which Bloomberg News described as, “Where the brightest minds from the science-entrepreneurship ecosystem meet
Kepley BioSystems Selected as a Hello Tomorrow Challenge Finalist
Competing with 70 other extraordinary startup companies from around the world, Kepley BioSystems was named as a top finalist in the Hello Tomorrow Challenge. Originally, 3,500 companies from 105 countries had entered the competition, and recently the field was narrowed to 500 semi-finalists. Now, just 70 companies that have been invited to make presentations at the Hello Tomorrow Global Summit on October 13 and 14 in Paris, France, where they
Life Sciences Start-Up Designates Vessel for Research into Blue Ocean Technologi …
Greensboro, North Carolina, Life sciences start-up, Kepley BioSystems Inc. recently took the next step in its blue ocean technologies development efforts. A boat belonging to lead inventor and long-time resident of the island of Anguilla, Terry Brady, was designated as the first official Kepley BioSystems Research Vessel. The ceremony took place on a majestic beach in picturesque Anguilla, British West Indies, and began with welcoming remarks by Professor Delroy